Remimazolam attenuated lipopolysaccharide-induced behavioral deficits and neuronal injury via activation of the Nrf2 pathway
Abstract Sepsis is a severe disorder that is always accompanied by brain injury and dysfunction. This study aimed to evaluate the effects of remimazolam, a new ultra-short-acting sedative, on LPS-induced neuronal injury, and the role of Nrf2 signaling pathway involved. LPS was administered to Spragu...
Saved in:
| Main Authors: | Yi Wei, Sining Pan, Zhan Zhou, Ying Yang, Tianxiao Liu, Jing Chen, Yubo Xie |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-95379-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Remimazolam attenuates intestinal ischemia-reperfusion injury in mice by regulating ferroptosis through CX43
by: KONG Lingguo, et al.
Published: (2025-08-01) -
Remimazolam in children: a comprehensive narrative review
by: Tom G. Hansen, et al.
Published: (2025-02-01) -
Remimazolam and propofol combination in ischemic cerebrovascular disease endovascular treatment: a randomized study
by: Tianxiao Liu, et al.
Published: (2025-07-01) -
Application of remimazolam besylate combined with esketamine in outpatient colonoscopy in patients with hypertension
by: GUO Xiaoyang, LI Wei, HAO Zaijun
Published: (2025-05-01) -
Comparative study of different administration orders of remimazolam and propofol in painless gastroscopy
by: JIANG Huiping, et al.
Published: (2024-05-01)